A detailed history of Jane Street Group, LLC transactions in Cv Rx, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 19,038 shares of CVRX stock, worth $256,251. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,038
Previous 13,985 36.13%
Holding current value
$256,251
Previous $167,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$7.15 - $12.37 $36,128 - $62,505
5,053 Added 36.13%
19,038 $167,000
Q2 2024

Aug 14, 2024

SELL
$6.49 - $19.2 $11,896 - $35,193
-1,833 Reduced 11.59%
13,985 $167,000
Q1 2024

May 15, 2024

SELL
$17.99 - $30.49 $126,217 - $213,917
-7,016 Reduced 30.73%
15,818 $288,000
Q4 2023

Feb 14, 2024

BUY
$11.67 - $33.01 $266,472 - $753,750
22,834 New
22,834 $717,000
Q2 2023

Aug 14, 2023

SELL
$8.57 - $15.44 $99,969 - $180,107
-11,665 Reduced 31.66%
25,177 $388,000
Q1 2023

May 15, 2023

BUY
$7.08 - $19.4 $260,841 - $714,734
36,842 New
36,842 $343,000
Q1 2022

May 17, 2022

SELL
$5.62 - $12.37 $91,184 - $200,703
-16,225 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$10.65 - $18.61 $172,796 - $301,947
16,225 New
16,225 $198,000

Others Institutions Holding CVRX

About CVRx, Inc.


  • Ticker CVRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 20,576,200
  • Market Cap $277M
  • Description
  • CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The co...
More about CVRX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.